Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.60 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.59 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | FYN | P06241 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | HTR2A | P28223 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL450849 | 0.91 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL671002 | 0.91 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL22645606 | 0.91 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL1639831 | 0.88 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL4287070 | 0.85 | ITGB3 (0.58) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL28447519 | 0.85 | SLC7A5 (0.57) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL27971967 | 0.85 | SLC7A5 (0.57) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL1537419 | 0.85 | ITGB3 (0.58) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL4410810 | 0.85 | SLC7A5 (0.66) | SLC7A5PTGS1ALPIPKMXIAP | |
| SCHEMBL3261478 | 0.85 | SLC7A5 (0.57) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120132207-A | Electric controlled release separable microneedle patch and drug delivery device | 成都邦迈医创科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| WO-2025084687-A1 | DRUG DELIVERY DEVICE KIT FOR IN VIVO IMPLANTATION | 투바이오스 주식회사 | 2025-04-24 | — | — | WO | claimed |
| US-12233229-B2 | Perforated plate microstructure module | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2025-02-25 | — | — | US | claimed |
| EP-4373419-A1 | FIBER-REINFORCED BIOCOMPOSITE MEDICAL IMPLANTS WITH DEFORMABLE PROTRUSIONS AND METHODS OF USE THEREOF | Ossio Ltd. (IL) | 2024-05-29 | — | — | EP | claimed |
| WO-2024105655-A1 | FIBER-REINFORCED ORTHOPEDIC COMPRESSION STAPLE | Ossio Ltd. (IL) | 2024-05-23 | — | — | WO | claimed |
| US-20240115775-A1 | CONTINUOUS-FIBER REINFORCED BIOCOMPOSITE MEDICAL IMPLANTS | OSSIO INC. | 2024-04-11 | — | — | US | claimed |
| US-11883508-B2 | Method for culturing 3-dimensional lung cancer organoid and method for preparing patient-derived xenograft animal model using same | ONCOCLEW CO., LTD. (KR) | 2024-01-30 | — | — | US | claimed |
| EP-3628249-B1 | CONTINUOUS-FIBER REINFORCED BIOCOMPOSITE MEDICAL IMPLANTS | OSSIO LTD (IL) | 2023-12-06 | — | — | EP | claimed |
| WO-2023195666-A1 | DRUG INJECTION DEVICE | 서울대학교산학협력단 | 2023-10-12 | — | — | WO | claimed |
| CN-116831975-A | Microneedle patch for inducing immune tolerance to treat rheumatoid arthritis | 四川大学 | 2023-10-03 | — | — | CN | claimed |
| WO-2016035088-A1 | ANISOTROPIC BIOCOMPOSITE MATERIAL, MEDICAL IMPLANTS COMPRISING SAME AND METHODS OF TREATMENT THEREOF | RESORBIUM LTD. (IL) | 2016-03-10 | — | — | WO | claimed |
| US-20160038641-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | HUMAN BIOMOLECULAR RESEARCH INSTITUTE (US) | 2016-02-11 | — | — | US | claimed |
| EP-2398511-B1 | MEDICAL DEVICE AND METHOD FOR MAKING THE SAME | SOFRADIM PRODUCTION (FR) | 2013-04-17 | — | — | EP | claimed |
| US-20120021217-A1 | FIBERS WITH AN ACTIVATED SURFACE AND METHOD OF MAKING SAME BY EXTRUSION | COVIDIEN LP | 2012-01-26 | — | — | US | claimed |
| EP-2314328-A2 | Reactive surgical implant | Tyco Healthcare Group LP (US) | 2011-04-27 | — | — | EP | claimed |
| WO-2010095057-A1 | FIBERS WITH AN ACTIVATED SURFACE AND METHOD OF MAKING SAME BY EXTRUSION | SOFRADIM PRODUCTION (FR) | 2010-08-26 | — | — | WO | claimed |
| US-20100104608-A1 | REACTIVE SURGICAL IMPLANT | TYCO HEALTHCARE GROUP LP (US) | 2010-04-29 | — | — | US | claimed |
| WO-2007005180-A9 | METHOD FOR ENHANCING ENGRAFTMENT OF THERAPEUTIC CELLS AT A TARGET SITE | ADVANCED CARDIOVASCULAR SYSTEM (US) | 2007-04-05 | — | — | WO | claimed |
| WO-2007005180-A2 | METHOD FOR ENHANCING ENGRAFTMENT OF THERAPEUTIC CELLS AT A TARGET SITE | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-01-11 | — | — | WO | claimed |
| US-20070003528-A1 | Intracoronary device and method of use thereof | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-01-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104608-A1 | REACTIVE SURGICAL IMPLANT | ECPAS, STIM2, STUB1 | SLC7A5 4504/4885PTGS1 897/4885ALPI 3381/4885 |
| US-20160038641-A1 | COMPOUNDS AND MATRICES FOR USE IN BONE GROWTH AND REPAIR | BMP2, BMP4, BMP6 | SLC7A5 2466/4885PTGS1 435/4885ALPI 310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.